Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Methodology

Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples

Authors: Meera Venkatesan, Chanaki Amaratunga, Susana Campino, Sarah Auburn, Oliver Koch, Pharath Lim, Sambunny Uk, Duong Socheat, Dominic P Kwiatkowski, Rick M Fairhurst, Christopher V Plowe

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

Genome and transcriptome studies of Plasmodium nucleic acids obtained from parasitized whole blood are greatly improved by depletion of human DNA or enrichment of parasite DNA prior to next-generation sequencing and microarray hybridization. The most effective method currently used is a two-step procedure to deplete leukocytes: centrifugation using density gradient media followed by filtration through expensive, commercially available columns. This method is not easily implemented in field studies that collect hundreds of samples and simultaneously process samples for multiple laboratory analyses. Inexpensive syringes, hand-packed with CF11 cellulose powder, were recently shown to improve ex vivo cultivation of Plasmodium vivax obtained from parasitized whole blood. This study was undertaken to determine whether CF11 columns could be adapted to isolate Plasmodium falciparum DNA from parasitized whole blood and achieve current quantity and purity requirements for Illumina sequencing.

Methods

The CF11 procedure was compared with the current two-step standard of leukocyte depletion using parasitized red blood cells cultured in vitro and parasitized blood obtained ex vivo from Cambodian patients with malaria. Procedural variations in centrifugation and column size were tested, along with a range of blood volumes and parasite densities.

Results

CF11 filtration reliably produces 500 nanograms of DNA with less than 50% human DNA contamination, which is comparable to that obtained by the two-step method and falls within the current quality control requirements for Illumina sequencing. In addition, a centrifuge-free version of the CF11 filtration method to isolate P. falciparum DNA at remote and minimally equipped field sites in malaria-endemic areas was validated.

Conclusions

CF11 filtration is a cost-effective, scalable, one-step approach to remove human DNA from P. falciparum-infected whole blood samples.
Appendix
Available only for authorised users
Literature
1.
go back to reference Mok S, Imwong M, Mackinnon MJ, Sim J, Ramadoss R, Yi P, Mayxay M, Chotivanich K, Liong KY, Russel B, Socheat D, Newton PN, Day NP, White NJ, Preiser PR, Nosten F, Dondorp AM, Bozdech Z: Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics. 2011, 12: 391-10.1186/1471-2164-12-391.PubMedCentralCrossRefPubMed Mok S, Imwong M, Mackinnon MJ, Sim J, Ramadoss R, Yi P, Mayxay M, Chotivanich K, Liong KY, Russel B, Socheat D, Newton PN, Day NP, White NJ, Preiser PR, Nosten F, Dondorp AM, Bozdech Z: Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription. BMC Genomics. 2011, 12: 391-10.1186/1471-2164-12-391.PubMedCentralCrossRefPubMed
2.
go back to reference Dharia NV, Bright AT, Westenberger SJ, Barnes SW, Batalov S, Kuhen K, Borboa R, Federe GC, McClean CM, Vinetz JM, Neyra V, Llanos-Cuentas A, Barnwell JW, Walker JR, Winzeler EA: Whole-genome sequencing and microarray analysis of ex vivo Plasmodium viva reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci USA. 2010, 107: 20045-20050. 10.1073/pnas.1003776107.PubMedCentralCrossRefPubMed Dharia NV, Bright AT, Westenberger SJ, Barnes SW, Batalov S, Kuhen K, Borboa R, Federe GC, McClean CM, Vinetz JM, Neyra V, Llanos-Cuentas A, Barnwell JW, Walker JR, Winzeler EA: Whole-genome sequencing and microarray analysis of ex vivo Plasmodium viva reveal selective pressure on putative drug resistance genes. Proc Natl Acad Sci USA. 2010, 107: 20045-20050. 10.1073/pnas.1003776107.PubMedCentralCrossRefPubMed
3.
go back to reference Auburn S, Campino S, Clark TG, Djimde AA, Zongo I, Pinches R, Manske M, Mangano V, Alcock D, Anastasi E, Maslen G, Macinnis B, Rockett K, Modiano D, Newbold CI, Doumbo OK, Ouédraogo JB, Kwiatkowski DP: An effective method to purify Plasmodium falciparu DNA directly from clinical blood samples for whole genome high-throughput sequencing. PLoS One. 2011, 6: e22213-10.1371/journal.pone.0022213.PubMedCentralCrossRefPubMed Auburn S, Campino S, Clark TG, Djimde AA, Zongo I, Pinches R, Manske M, Mangano V, Alcock D, Anastasi E, Maslen G, Macinnis B, Rockett K, Modiano D, Newbold CI, Doumbo OK, Ouédraogo JB, Kwiatkowski DP: An effective method to purify Plasmodium falciparu DNA directly from clinical blood samples for whole genome high-throughput sequencing. PLoS One. 2011, 6: e22213-10.1371/journal.pone.0022213.PubMedCentralCrossRefPubMed
4.
go back to reference Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, Fennell T, Giannoukos G, Fisher S, Russ C, Gabriel S, Jaffe DB, Lander ES, Nusbaum C: Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009, 27: 182-189. 10.1038/nbt.1523.PubMedCentralCrossRefPubMed Gnirke A, Melnikov A, Maguire J, Rogov P, LeProust EM, Brockman W, Fennell T, Giannoukos G, Fisher S, Russ C, Gabriel S, Jaffe DB, Lander ES, Nusbaum C: Solution hybrid selection with ultra-long oligonucleotides for massively parallel targeted sequencing. Nat Biotechnol. 2009, 27: 182-189. 10.1038/nbt.1523.PubMedCentralCrossRefPubMed
5.
go back to reference Melnikov A, Galinsky K, Rogov P, Fennell T, Tyne DV, Russ C, Daniels R, Barnes KG, Bochicchio J, Ndiaye D, Sene PD, Wirth DF, Nusbaum C, Volkman SK, Birren BW, Gnirke A, Neafsey DE: Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol. 2011, 12: R73-10.1186/gb-2011-12-8-r73.PubMedCentralCrossRefPubMed Melnikov A, Galinsky K, Rogov P, Fennell T, Tyne DV, Russ C, Daniels R, Barnes KG, Bochicchio J, Ndiaye D, Sene PD, Wirth DF, Nusbaum C, Volkman SK, Birren BW, Gnirke A, Neafsey DE: Hybrid selection for sequencing pathogen genomes from clinical samples. Genome Biol. 2011, 12: R73-10.1186/gb-2011-12-8-r73.PubMedCentralCrossRefPubMed
6.
go back to reference Trang DT, Huy NT, Kariu T, Tajima K, Kamei K: One-step concentration of malarial parasite-infected red blood cells and removal of contaminating white blood cells. Malar J. 2004, 3: 7-10.1186/1475-2875-3-7.PubMedCentralCrossRefPubMed Trang DT, Huy NT, Kariu T, Tajima K, Kamei K: One-step concentration of malarial parasite-infected red blood cells and removal of contaminating white blood cells. Malar J. 2004, 3: 7-10.1186/1475-2875-3-7.PubMedCentralCrossRefPubMed
8.
go back to reference Waki S, Suzuki M: Concentration of Plasmodium viva-infected erythrocytes. Ann Trop Med Parasitol. 1986, 80: 125-126.PubMed Waki S, Suzuki M: Concentration of Plasmodium viva-infected erythrocytes. Ann Trop Med Parasitol. 1986, 80: 125-126.PubMed
9.
go back to reference Tao ZY, Xia H, Cao J, Gao Q: Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood. Malar J. 2011, 10: 251-10.1186/1475-2875-10-251.PubMedCentralCrossRefPubMed Tao ZY, Xia H, Cao J, Gao Q: Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood. Malar J. 2011, 10: 251-10.1186/1475-2875-10-251.PubMedCentralCrossRefPubMed
10.
go back to reference Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F: Effective and cheap removal of leukocytes and platelets from Plasmodium viva infected blood. Malar J. 2009, 8: 115-10.1186/1475-2875-8-115.PubMedCentralCrossRefPubMed Sriprawat K, Kaewpongsri S, Suwanarusk R, Leimanis ML, Lek-Uthai U, Phyo AP, Snounou G, Russell B, Renia L, Nosten F: Effective and cheap removal of leukocytes and platelets from Plasmodium viva infected blood. Malar J. 2009, 8: 115-10.1186/1475-2875-8-115.PubMedCentralCrossRefPubMed
11.
go back to reference Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR: The transcriptome of Plasmodium viva reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA. 2008, 105: 16290-16295. 10.1073/pnas.0807404105.PubMedCentralCrossRefPubMed Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR: The transcriptome of Plasmodium viva reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA. 2008, 105: 16290-16295. 10.1073/pnas.0807404105.PubMedCentralCrossRefPubMed
13.
go back to reference Wang Y, Nair S, Nosten F, Anderson TJ: Multiple displacement amplification for malaria parasite DNA. J Parasitol. 2009, 95: 253-255. 10.1645/GE-1706.1.PubMedCentralCrossRefPubMed Wang Y, Nair S, Nosten F, Anderson TJ: Multiple displacement amplification for malaria parasite DNA. J Parasitol. 2009, 95: 253-255. 10.1645/GE-1706.1.PubMedCentralCrossRefPubMed
Metadata
Title
Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples
Authors
Meera Venkatesan
Chanaki Amaratunga
Susana Campino
Sarah Auburn
Oliver Koch
Pharath Lim
Sambunny Uk
Duong Socheat
Dominic P Kwiatkowski
Rick M Fairhurst
Christopher V Plowe
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-41

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine